Liza Dawson

1.5k total citations
28 papers, 663 citations indexed

About

Liza Dawson is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Liza Dawson has authored 28 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Epidemiology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Liza Dawson's work include Ethics in Clinical Research (11 papers), HIV/AIDS Research and Interventions (7 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Liza Dawson is often cited by papers focused on Ethics in Clinical Research (11 papers), HIV/AIDS Research and Interventions (7 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Liza Dawson collaborates with scholars based in United States, South Africa and Germany. Liza Dawson's co-authors include Nancy Kass, Xiao-Fang Yu, Xiao-Fang Yu, Adnan A. Hyder, Bindong Liu, Robert J. Gorelick, Abdulgafoor M. Bachani, James V. Lavery, Charles Flexner and Markus Dettenhofer and has published in prestigious journals such as The Lancet, Journal of Virology and Social Science & Medicine.

In The Last Decade

Liza Dawson

26 papers receiving 635 citations

Peers

Liza Dawson
Scott McCoombe Australia
Melissa Sanchez United States
Rushina Cholera United States
Kathleen A. McGann United States
Timothy Lahey United States
Scott H. Barnett United States
Annet Kembabazi United States
Chris Kenyon Belgium
Scott McCoombe Australia
Liza Dawson
Citations per year, relative to Liza Dawson Liza Dawson (= 1×) peers Scott McCoombe

Countries citing papers authored by Liza Dawson

Since Specialization
Citations

This map shows the geographic impact of Liza Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liza Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liza Dawson more than expected).

Fields of papers citing papers by Liza Dawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liza Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liza Dawson. The network helps show where Liza Dawson may publish in the future.

Co-authorship network of co-authors of Liza Dawson

This figure shows the co-authorship network connecting the top 25 collaborators of Liza Dawson. A scholar is included among the top collaborators of Liza Dawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liza Dawson. Liza Dawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dawson, Liza, Benjamin S. Wilfond, Andrew D. Ray, & Liza‐Marie Johnson. (2025). Delivery of Elexacaftor/Tezacaftor/Ivacaftor (ETI) Through Placenta and Then Breastmilk in Cystic Fibrosis: A Clinical Trial Risk-Benefit Analysis. The American Journal of Bioethics. 25(10). 97–99.
2.
Johnson, Liza‐Marie, Benjamin S. Wilfond, Andrew D. Ray, & Liza Dawson. (2025). Institutional Access to Gene Therapy for Sickle Cell Disease – Treatment on a Clinical Trial or Receive a Newly Approved Therapy?. The American Journal of Bioethics. 25(4). 145–146.
3.
Ray, Andrew D., Liza Dawson, Benjamin S. Wilfond, & Liza‐Marie Johnson. (2024). Disclosing Interim Results to Parents Offered Enrollment in a Fetal Intervention Trial. The American Journal of Bioethics. 24(10). 113–114. 1 indexed citations
4.
Dawson, Liza, Andrew D. Ray, Benjamin S. Wilfond, & Liza‐Marie Johnson. (2024). To Swab or Not to Swab: Waiver of Consent to Collect Perianal Specimens from Incapacitated Patients With Severe Burn Injury. The American Journal of Bioethics. 24(4). 108–109. 2 indexed citations
5.
Dawson, Liza, et al.. (2024). The Social Value Misconception in Clinical Research. The American Journal of Bioethics. 25(8). 61–77. 2 indexed citations
6.
Smith, Hunter Jackson, et al.. (2023). The Ethics of Personal Behaviors for Preventing Infectious Diseases in a Post–COVID-19 Pandemic World. Public Health Reports. 138(5). 822–828. 1 indexed citations
7.
Dawson, Liza, Nanette Benbow, Faith E. Fletcher, et al.. (2020). Addressing Ethical Challenges in US-Based HIV Phylogenetic Research. The Journal of Infectious Diseases. 222(12). 1997–2006. 23 indexed citations
8.
Dawson, Liza, Steffanie A. Strathdee, Alex John London, et al.. (2016). Addressing ethical challenges in HIV prevention research with people who inject drugs. Journal of Medical Ethics. 44(3). 149–158. 7 indexed citations
9.
Dawson, Liza, Chuka Anude, Paul Ndebele, et al.. (2015). Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial. Clinical Trials. 12(4). 394–402. 8 indexed citations
10.
Anude, Chuka, et al.. (2014). Ethical Considerations in HIV Prevention and Vaccine Research in Resource-Limited Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(1). 77–83. 2 indexed citations
11.
Dawson, Liza & Sheryl Zwerski. (2014). Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention. Bioethics. 29(5). 316–323. 8 indexed citations
12.
Dawson, Liza, Karin L. Klingman, & Jeanne Marrazzo. (2013). Addressing Standards of Care in Resource-Limited Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(Supplement 1). S10–S14. 9 indexed citations
13.
Hyder, Adnan A., Liza Dawson, Abdulgafoor M. Bachani, & James V. Lavery. (2009). Moving from research ethics review to research ethics systems in low-income and middle-income countries. The Lancet. 373(9666). 862–865. 46 indexed citations
14.
Dawson, Liza, Deborah A. Zarin, Ezekiel J. Emanuel, et al.. (2009). Considering Usual Medical Care in Clinical Trial Design. PLoS Medicine. 6(9). e1000111–e1000111. 41 indexed citations
15.
Hyder, Adnan A. & Liza Dawson. (2005). DEFINING STANDARD OF CARE IN THE DEVELOPING WORLD: THE INTERSECTION OF INTERNATIONAL RESEARCH ETHICS AND HEALTH SYSTEMS ANALYSIS. Developing World Bioethics. 5(2). 142–152. 20 indexed citations
16.
Dawson, Liza & Nancy Kass. (2005). Views of US researchers about informed consent in international collaborative research. Social Science & Medicine. 61(6). 1211–1222. 77 indexed citations
17.
Dawson, Liza, Alison Bateman-House, Hilary Bok, et al.. (2003). Safety issues in cell-based intervention trials. Fertility and Sterility. 80(5). 1077–1085. 48 indexed citations
18.
Liu, Bindong, et al.. (1999). Interaction of the Human Immunodeficiency Virus Type 1 Nucleocapsid with Actin. Journal of Virology. 73(4). 2901–2908. 118 indexed citations
19.
Dawson, Liza & Xiao-Fang Yu. (1998). The Role of Nucleocapsid of HIV-1 in Virus Assembly. Virology. 251(1). 141–157. 92 indexed citations
20.
Yu, Xiao-Fang, et al.. (1998). Mutations of the Human Immunodeficiency Virus Type 1 p6 Gag Domain Result in Reduced Retention of Pol Proteins during Virus Assembly. Journal of Virology. 72(4). 3412–3417. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026